MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 153 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $18,000 | -78.8% | 14,800 | +46.5% | 0.00% | – |
| Q1 2016 | $85,000 | -78.9% | 10,100 | -76.2% | 0.00% | -100.0% |
| Q3 2015 | $402,000 | -68.6% | 42,526 | -59.0% | 0.00% | -70.0% |
| Q2 2015 | $1,281,000 | -43.0% | 103,606 | -45.2% | 0.01% | -41.2% |
| Q1 2015 | $2,248,000 | +38.2% | 189,226 | +31.5% | 0.02% | +30.8% |
| Q4 2014 | $1,627,000 | +247.6% | 143,946 | +169.9% | 0.01% | +225.0% |
| Q3 2014 | $468,000 | +190.7% | 53,326 | +142.1% | 0.00% | +300.0% |
| Q2 2014 | $161,000 | – | 22,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
| KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
| Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
| GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
| Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
| Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
| Birchview Capital, LP | 44,000 | $136,000 | 0.08% |